| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fragile X Syndrome | 79 | 2022 | 150 | 7.270 |
Why?
|
| Fragile X Mental Retardation Protein | 57 | 2022 | 125 | 4.530 |
Why?
|
| RNA-Binding Proteins | 43 | 2022 | 577 | 3.490 |
Why?
|
| Cytochrome P-450 Enzyme System | 18 | 2024 | 136 | 2.350 |
Why?
|
| X Chromosome | 43 | 2002 | 337 | 2.240 |
Why?
|
| Nerve Tissue Proteins | 38 | 2016 | 1114 | 1.900 |
Why?
|
| Antiviral Agents | 13 | 2022 | 746 | 1.810 |
Why?
|
| Hepatitis C, Chronic | 8 | 2022 | 324 | 1.800 |
Why?
|
| Trinucleotide Repeat Expansion | 11 | 2021 | 124 | 1.770 |
Why?
|
| Tremor | 6 | 2022 | 130 | 1.760 |
Why?
|
| Ataxia | 6 | 2022 | 168 | 1.740 |
Why?
|
| Genetics, Medical | 6 | 2024 | 117 | 1.550 |
Why?
|
| Genome | 10 | 2025 | 476 | 1.490 |
Why?
|
| Evolution, Molecular | 26 | 2024 | 672 | 1.430 |
Why?
|
| Human Genetics | 3 | 2024 | 7 | 1.290 |
Why?
|
| Hepatitis C | 5 | 2022 | 364 | 1.210 |
Why?
|
| Hepacivirus | 9 | 2022 | 241 | 1.160 |
Why?
|
| Genetic Variation | 14 | 2021 | 1492 | 1.140 |
Why?
|
| Multigene Family | 18 | 2020 | 298 | 1.120 |
Why?
|
| Molecular Sequence Data | 66 | 2015 | 3873 | 1.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 37 | 2011 | 369 | 1.080 |
Why?
|
| Gorilla gorilla | 3 | 2025 | 12 | 1.080 |
Why?
|
| Incontinentia Pigmenti | 11 | 2006 | 16 | 1.010 |
Why?
|
| Mutation | 35 | 2021 | 5809 | 0.950 |
Why?
|
| Genome, Fungal | 7 | 2019 | 31 | 0.950 |
Why?
|
| RNA, Messenger | 18 | 2017 | 2824 | 0.940 |
Why?
|
| Haplotypes | 9 | 2025 | 520 | 0.930 |
Why?
|
| Behavior, Animal | 11 | 2020 | 492 | 0.920 |
Why?
|
| Animals | 116 | 2025 | 34139 | 0.900 |
Why?
|
| Chromosome Mapping | 27 | 2005 | 1082 | 0.900 |
Why?
|
| Trinucleotide Repeats | 12 | 2013 | 110 | 0.900 |
Why?
|
| Telomere | 1 | 2025 | 208 | 0.870 |
Why?
|
| Phylogeny | 27 | 2020 | 696 | 0.870 |
Why?
|
| Saccharomyces cerevisiae | 8 | 2021 | 426 | 0.830 |
Why?
|
| Biological Evolution | 12 | 2024 | 224 | 0.830 |
Why?
|
| Circadian Rhythm | 6 | 2014 | 274 | 0.820 |
Why?
|
| Drosophila Proteins | 8 | 2014 | 723 | 0.820 |
Why?
|
| Transcriptome | 5 | 2024 | 937 | 0.810 |
Why?
|
| Biomedical Research | 2 | 2019 | 518 | 0.790 |
Why?
|
| Disease Models, Animal | 25 | 2022 | 4355 | 0.780 |
Why?
|
| Sequence Analysis, DNA | 23 | 2024 | 1762 | 0.780 |
Why?
|
| Drosophila | 8 | 2019 | 781 | 0.760 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2021 | 446 | 0.740 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 42 | 0.720 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 708 | 0.720 |
Why?
|
| Base Sequence | 51 | 2014 | 3093 | 0.720 |
Why?
|
| Secondary Metabolism | 5 | 2020 | 5 | 0.720 |
Why?
|
| Microsatellite Repeats | 5 | 2013 | 219 | 0.710 |
Why?
|
| Mice | 62 | 2022 | 17725 | 0.710 |
Why?
|
| Humans | 182 | 2025 | 124398 | 0.680 |
Why?
|
| Alleles | 22 | 2024 | 1614 | 0.680 |
Why?
|
| Vibrio | 2 | 2011 | 11 | 0.680 |
Why?
|
| Chromosomes, Human, X | 4 | 2009 | 157 | 0.670 |
Why?
|
| Nuclear Proteins | 13 | 2021 | 1272 | 0.660 |
Why?
|
| Long-Term Potentiation | 4 | 2014 | 164 | 0.630 |
Why?
|
| Mycobacterium | 4 | 2020 | 28 | 0.630 |
Why?
|
| Trans-Activators | 10 | 2014 | 807 | 0.600 |
Why?
|
| Genome, Plant | 8 | 2024 | 23 | 0.600 |
Why?
|
| Ribavirin | 4 | 2021 | 80 | 0.600 |
Why?
|
| Genome, Human | 13 | 2024 | 1273 | 0.570 |
Why?
|
| Drug Users | 1 | 2017 | 8 | 0.560 |
Why?
|
| Bacterial Proteins | 5 | 2020 | 886 | 0.560 |
Why?
|
| Genetic Drift | 4 | 2019 | 22 | 0.550 |
Why?
|
| Male | 103 | 2025 | 61025 | 0.550 |
Why?
|
| Neurons | 11 | 2021 | 1964 | 0.550 |
Why?
|
| Genes | 16 | 2007 | 444 | 0.540 |
Why?
|
| Mice, Knockout | 26 | 2021 | 3753 | 0.530 |
Why?
|
| Genetic Research | 1 | 2017 | 56 | 0.530 |
Why?
|
| Linkage Disequilibrium | 7 | 2006 | 309 | 0.520 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 196 | 0.520 |
Why?
|
| Awards and Prizes | 1 | 2017 | 64 | 0.510 |
Why?
|
| Amino Acid Sequence | 26 | 2019 | 2699 | 0.510 |
Why?
|
| Gene Editing | 1 | 2018 | 193 | 0.500 |
Why?
|
| Imidazoles | 3 | 2021 | 194 | 0.500 |
Why?
|
| Hippocampus | 8 | 2011 | 830 | 0.500 |
Why?
|
| Mental Retardation, X-Linked | 2 | 2009 | 78 | 0.500 |
Why?
|
| Hypothyroidism | 2 | 2015 | 93 | 0.500 |
Why?
|
| Cloning, Molecular | 19 | 2008 | 892 | 0.500 |
Why?
|
| Uridine Monophosphate | 1 | 2015 | 8 | 0.490 |
Why?
|
| Ganoderma | 1 | 2015 | 1 | 0.490 |
Why?
|
| Societies, Medical | 1 | 2019 | 683 | 0.480 |
Why?
|
| Gene Expression | 14 | 2019 | 1569 | 0.480 |
Why?
|
| Genome, Insect | 4 | 2021 | 96 | 0.470 |
Why?
|
| Genetic Therapy | 3 | 2018 | 683 | 0.470 |
Why?
|
| Patient Selection | 2 | 2017 | 688 | 0.450 |
Why?
|
| Polymerase Chain Reaction | 25 | 2014 | 1584 | 0.450 |
Why?
|
| Hemolysin Proteins | 2 | 2011 | 32 | 0.450 |
Why?
|
| Protein Biosynthesis | 9 | 2022 | 665 | 0.440 |
Why?
|
| Models, Genetic | 11 | 2019 | 759 | 0.430 |
Why?
|
| Female | 80 | 2025 | 66305 | 0.420 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2012 | 2615 | 0.420 |
Why?
|
| Exons | 19 | 2019 | 796 | 0.420 |
Why?
|
| DNA-Binding Proteins | 8 | 2014 | 2055 | 0.420 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2011 | 157 | 0.410 |
Why?
|
| Intellectual Disability | 6 | 2019 | 1061 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 16 | 2020 | 4425 | 0.400 |
Why?
|
| Stillbirth | 1 | 2013 | 80 | 0.400 |
Why?
|
| Nervous System Diseases | 2 | 2013 | 376 | 0.400 |
Why?
|
| DNA | 24 | 2004 | 1598 | 0.400 |
Why?
|
| Chromosomes, Artificial, Yeast | 8 | 2002 | 41 | 0.390 |
Why?
|
| Eye | 5 | 2011 | 227 | 0.390 |
Why?
|
| History, 21st Century | 4 | 2024 | 269 | 0.390 |
Why?
|
| Pan troglodytes | 5 | 2006 | 71 | 0.380 |
Why?
|
| Pedigree | 24 | 2012 | 1596 | 0.380 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2012 | 36 | 0.380 |
Why?
|
| Spinocerebellar Ataxias | 4 | 2013 | 252 | 0.380 |
Why?
|
| History, 20th Century | 4 | 2024 | 384 | 0.370 |
Why?
|
| Phenotype | 16 | 2021 | 4255 | 0.370 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 112 | 0.370 |
Why?
|
| Selection, Genetic | 6 | 2018 | 155 | 0.360 |
Why?
|
| Glucose | 2 | 2014 | 885 | 0.360 |
Why?
|
| DNA Repeat Expansion | 2 | 2013 | 64 | 0.350 |
Why?
|
| Cyanobacteria | 2 | 2020 | 10 | 0.350 |
Why?
|
| I-kappa B Kinase | 5 | 2006 | 61 | 0.340 |
Why?
|
| Streptomyces | 2 | 2020 | 14 | 0.340 |
Why?
|
| Synapses | 2 | 2014 | 460 | 0.330 |
Why?
|
| Bacillus | 2 | 2020 | 35 | 0.330 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2020 | 188 | 0.330 |
Why?
|
| Chromosomes, Fungal | 7 | 2009 | 49 | 0.330 |
Why?
|
| Hominidae | 5 | 2003 | 27 | 0.320 |
Why?
|
| Muscle, Skeletal | 4 | 2019 | 951 | 0.320 |
Why?
|
| Chromosome Deletion | 4 | 2007 | 647 | 0.310 |
Why?
|
| Transcription Factors | 10 | 2016 | 2607 | 0.310 |
Why?
|
| Mice, Transgenic | 12 | 2019 | 2408 | 0.310 |
Why?
|
| Fungal Proteins | 5 | 2019 | 134 | 0.310 |
Why?
|
| Genomics | 8 | 2024 | 1490 | 0.310 |
Why?
|
| Myotonic Dystrophy | 5 | 2013 | 148 | 0.310 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2009 | 131 | 0.300 |
Why?
|
| RNA-Induced Silencing Complex | 2 | 2007 | 12 | 0.300 |
Why?
|
| Cell Line | 16 | 2014 | 2770 | 0.300 |
Why?
|
| Gene Deletion | 4 | 2011 | 795 | 0.300 |
Why?
|
| Sofosbuvir | 3 | 2021 | 14 | 0.300 |
Why?
|
| Secretin | 3 | 2008 | 15 | 0.300 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2011 | 657 | 0.280 |
Why?
|
| Adult | 22 | 2025 | 29396 | 0.280 |
Why?
|
| Oomycetes | 2 | 2018 | 2 | 0.280 |
Why?
|
| Protein C | 1 | 2007 | 21 | 0.280 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 174 | 0.270 |
Why?
|
| Animals, Genetically Modified | 6 | 2019 | 315 | 0.270 |
Why?
|
| Gene Duplication | 6 | 2018 | 358 | 0.270 |
Why?
|
| Carrier Proteins | 5 | 2001 | 1024 | 0.270 |
Why?
|
| Cytoskeletal Proteins | 3 | 2004 | 269 | 0.270 |
Why?
|
| Sulfonamides | 3 | 2021 | 261 | 0.260 |
Why?
|
| Proteins | 7 | 2001 | 1043 | 0.260 |
Why?
|
| NF-kappa B | 2 | 2006 | 459 | 0.260 |
Why?
|
| DNA Methylation | 4 | 2024 | 1002 | 0.250 |
Why?
|
| Alternative Splicing | 3 | 1999 | 350 | 0.250 |
Why?
|
| Primates | 3 | 2003 | 80 | 0.250 |
Why?
|
| Endangered Species | 1 | 2025 | 10 | 0.250 |
Why?
|
| Orchidaceae | 1 | 2024 | 1 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2011 | 1288 | 0.240 |
Why?
|
| Genes, Fungal | 3 | 2018 | 63 | 0.240 |
Why?
|
| Postnatal Care | 1 | 2025 | 51 | 0.240 |
Why?
|
| Adaptation, Physiological | 4 | 2016 | 270 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 3137 | 0.240 |
Why?
|
| Chromosomes, Mammalian | 1 | 2004 | 41 | 0.230 |
Why?
|
| Gene Amplification | 5 | 1995 | 228 | 0.230 |
Why?
|
| Oximes | 1 | 2024 | 50 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2004 | 40 | 0.230 |
Why?
|
| Genetic Fitness | 2 | 2016 | 34 | 0.230 |
Why?
|
| Carbamates | 2 | 2015 | 60 | 0.230 |
Why?
|
| Muscular Atrophy, Spinal | 3 | 1993 | 44 | 0.230 |
Why?
|
| Algorithms | 5 | 2022 | 1612 | 0.230 |
Why?
|
| Genetic Linkage | 12 | 2005 | 452 | 0.230 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2007 | 256 | 0.230 |
Why?
|
| Trisomy | 1 | 2004 | 103 | 0.230 |
Why?
|
| Gene Expression Regulation | 8 | 2016 | 2534 | 0.220 |
Why?
|
| Anti-Infective Agents | 1 | 2007 | 265 | 0.220 |
Why?
|
| Membrane Proteins | 4 | 2022 | 1530 | 0.220 |
Why?
|
| Tandem Repeat Sequences | 1 | 2024 | 37 | 0.220 |
Why?
|
| Gene Frequency | 10 | 2005 | 719 | 0.220 |
Why?
|
| Genotype | 8 | 2021 | 2552 | 0.220 |
Why?
|
| Young Adult | 8 | 2025 | 8979 | 0.220 |
Why?
|
| Chlamydomonas reinhardtii | 3 | 2015 | 4 | 0.220 |
Why?
|
| Metabolomics | 2 | 2024 | 420 | 0.220 |
Why?
|
| Genetics, Population | 2 | 2022 | 187 | 0.220 |
Why?
|
| Drug Therapy, Combination | 4 | 2021 | 1154 | 0.220 |
Why?
|
| Recombination, Genetic | 7 | 2004 | 447 | 0.220 |
Why?
|
| Fear | 4 | 2006 | 201 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 206 | 0.220 |
Why?
|
| Purkinje Cells | 3 | 2014 | 158 | 0.210 |
Why?
|
| Helminths | 1 | 2004 | 46 | 0.210 |
Why?
|
| Host-Parasite Interactions | 2 | 2021 | 70 | 0.210 |
Why?
|
| Insect Proteins | 3 | 2020 | 99 | 0.210 |
Why?
|
| Pseudogenes | 3 | 2002 | 53 | 0.210 |
Why?
|
| Terpenes | 1 | 2023 | 28 | 0.210 |
Why?
|
| Diterpenes | 1 | 2023 | 28 | 0.210 |
Why?
|
| Pain Management | 1 | 2025 | 181 | 0.210 |
Why?
|
| Blotting, Southern | 10 | 2002 | 215 | 0.210 |
Why?
|
| Chronic Pain | 1 | 2025 | 128 | 0.210 |
Why?
|
| Genes, Plant | 4 | 2020 | 28 | 0.210 |
Why?
|
| Middle Aged | 18 | 2025 | 26459 | 0.210 |
Why?
|
| Plankton | 1 | 2022 | 3 | 0.210 |
Why?
|
| RNA, Messenger, Stored | 1 | 2022 | 7 | 0.210 |
Why?
|
| Aged | 15 | 2025 | 19479 | 0.200 |
Why?
|
| Insecticide Resistance | 2 | 2020 | 29 | 0.200 |
Why?
|
| Spermatids | 1 | 2022 | 25 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2007 | 1174 | 0.200 |
Why?
|
| Sepsis | 1 | 2007 | 480 | 0.200 |
Why?
|
| Genes, Neoplasm | 1 | 2002 | 80 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2002 | 86 | 0.200 |
Why?
|
| Fishes | 2 | 2013 | 42 | 0.200 |
Why?
|
| Signal Transduction | 9 | 2022 | 4534 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2018 | 767 | 0.200 |
Why?
|
| Period Circadian Proteins | 2 | 2014 | 29 | 0.190 |
Why?
|
| Antibiosis | 1 | 2021 | 13 | 0.190 |
Why?
|
| Down Syndrome | 1 | 2004 | 198 | 0.190 |
Why?
|
| Valine | 3 | 2021 | 107 | 0.190 |
Why?
|
| Ecosystem | 3 | 2020 | 78 | 0.190 |
Why?
|
| Quinoxalines | 2 | 2021 | 39 | 0.190 |
Why?
|
| Ectopic Gene Expression | 1 | 2021 | 3 | 0.190 |
Why?
|
| Oocytes | 2 | 2021 | 284 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2011 | 764 | 0.190 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 29 | 0.190 |
Why?
|
| Treatment Failure | 1 | 2022 | 342 | 0.190 |
Why?
|
| Florida | 2 | 2019 | 78 | 0.190 |
Why?
|
| Gonadotropins | 1 | 2021 | 31 | 0.190 |
Why?
|
| Muscidae | 1 | 2021 | 2 | 0.190 |
Why?
|
| Fructokinases | 1 | 2021 | 2 | 0.190 |
Why?
|
| Receptors, Metabotropic Glutamate | 3 | 2011 | 45 | 0.180 |
Why?
|
| Spermatogenesis | 1 | 2022 | 171 | 0.180 |
Why?
|
| Insect Control | 1 | 2021 | 13 | 0.180 |
Why?
|
| Mammals | 2 | 2008 | 259 | 0.180 |
Why?
|
| Pharmacology, Clinical | 1 | 2021 | 5 | 0.180 |
Why?
|
| DNA Helicases | 2 | 2002 | 226 | 0.180 |
Why?
|
| ARNTL Transcription Factors | 2 | 2013 | 38 | 0.180 |
Why?
|
| Conserved Sequence | 6 | 2018 | 293 | 0.180 |
Why?
|
| Hepatocytes | 3 | 2011 | 229 | 0.180 |
Why?
|
| Cultural Characteristics | 1 | 2001 | 40 | 0.180 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2022 | 1000 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 266 | 0.180 |
Why?
|
| Indians, North American | 1 | 2001 | 59 | 0.180 |
Why?
|
| Codon | 1 | 2000 | 96 | 0.180 |
Why?
|
| Benzimidazoles | 2 | 2021 | 132 | 0.180 |
Why?
|
| Disease Resistance | 1 | 2020 | 23 | 0.180 |
Why?
|
| Brain | 12 | 2013 | 3003 | 0.180 |
Why?
|
| Minisatellite Repeats | 3 | 2002 | 43 | 0.180 |
Why?
|
| Zea mays | 1 | 2020 | 43 | 0.180 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 409 | 0.180 |
Why?
|
| DNA Mutational Analysis | 12 | 2002 | 788 | 0.180 |
Why?
|
| Coleoptera | 2 | 2018 | 13 | 0.180 |
Why?
|
| Chromosome Fragility | 3 | 1995 | 12 | 0.170 |
Why?
|
| Neural Inhibition | 2 | 2013 | 108 | 0.170 |
Why?
|
| Dosage Compensation, Genetic | 5 | 2005 | 59 | 0.170 |
Why?
|
| Prosencephalon | 1 | 2020 | 42 | 0.170 |
Why?
|
| Models, Statistical | 2 | 2018 | 472 | 0.170 |
Why?
|
| Sensory Gating | 2 | 2011 | 14 | 0.170 |
Why?
|
| Heteroptera | 1 | 2020 | 13 | 0.170 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 104 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2020 | 29 | 0.170 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 2014 | 286 | 0.170 |
Why?
|
| Machine Learning | 1 | 2022 | 242 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 1998 | 57 | 0.170 |
Why?
|
| Physician's Role | 1 | 2021 | 165 | 0.170 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 6 | 0.170 |
Why?
|
| Cytochrome P450 Family 51 | 1 | 2019 | 1 | 0.170 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 605 | 0.160 |
Why?
|
| Basidiomycota | 1 | 2019 | 11 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 79 | 0.160 |
Why?
|
| Hemolysis | 2 | 2011 | 109 | 0.160 |
Why?
|
| Serotonin | 1 | 2021 | 232 | 0.160 |
Why?
|
| Uracil | 2 | 2021 | 14 | 0.160 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2019 | 18 | 0.160 |
Why?
|
| Algal Proteins | 2 | 2010 | 3 | 0.160 |
Why?
|
| Sesquiterpenes | 1 | 2019 | 22 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2006 | 94 | 0.160 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2019 | 6 | 0.160 |
Why?
|
| Cytosine | 3 | 2013 | 56 | 0.160 |
Why?
|
| Intermediate Filament Proteins | 2 | 1990 | 27 | 0.160 |
Why?
|
| Chromosome Inversion | 2 | 2001 | 76 | 0.160 |
Why?
|
| Anilides | 2 | 2021 | 48 | 0.160 |
Why?
|
| California | 1 | 2019 | 128 | 0.160 |
Why?
|
| Fireflies | 1 | 2018 | 2 | 0.160 |
Why?
|
| Autistic Disorder | 1 | 2002 | 349 | 0.160 |
Why?
|
| Luciferases, Firefly | 1 | 2018 | 14 | 0.160 |
Why?
|
| Saccharum | 1 | 2018 | 7 | 0.160 |
Why?
|
| Pyrrolidines | 2 | 2017 | 36 | 0.160 |
Why?
|
| Plants | 4 | 2024 | 46 | 0.160 |
Why?
|
| Telemedicine | 1 | 2025 | 438 | 0.160 |
Why?
|
| Genes, Recessive | 2 | 2019 | 179 | 0.160 |
Why?
|
| Organ Specificity | 7 | 2017 | 426 | 0.160 |
Why?
|
| Polyploidy | 1 | 2018 | 15 | 0.150 |
Why?
|
| Interleukins | 2 | 2012 | 120 | 0.150 |
Why?
|
| Ophthalmoplegia | 1 | 2019 | 54 | 0.150 |
Why?
|
| Academies and Institutes | 1 | 2019 | 83 | 0.150 |
Why?
|
| Transcription, Genetic | 11 | 2011 | 1701 | 0.150 |
Why?
|
| Conidiobolus | 1 | 2018 | 1 | 0.150 |
Why?
|
| Molecular Sequence Annotation | 5 | 2018 | 149 | 0.150 |
Why?
|
| Peptides | 2 | 2021 | 793 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2019 | 4734 | 0.150 |
Why?
|
| In Vitro Techniques | 4 | 2016 | 969 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2014 | 389 | 0.150 |
Why?
|
| Interferon-alpha | 5 | 2011 | 221 | 0.150 |
Why?
|
| Sequence Tagged Sites | 3 | 1997 | 27 | 0.150 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 280 | 0.150 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 60 | 0.150 |
Why?
|
| Heterozygote | 6 | 2021 | 676 | 0.150 |
Why?
|
| Introns | 6 | 2013 | 300 | 0.150 |
Why?
|
| Restriction Mapping | 11 | 1997 | 188 | 0.150 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 158 | 0.150 |
Why?
|
| Time Factors | 6 | 2019 | 6272 | 0.150 |
Why?
|
| Dictyostelium | 1 | 2019 | 114 | 0.150 |
Why?
|
| Drosophila melanogaster | 6 | 2022 | 771 | 0.150 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2017 | 19 | 0.150 |
Why?
|
| Cosmids | 5 | 1996 | 48 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2020 | 372 | 0.150 |
Why?
|
| Taxus | 1 | 2017 | 1 | 0.150 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2017 | 22 | 0.150 |
Why?
|
| Pharmacogenomic Testing | 1 | 2017 | 37 | 0.140 |
Why?
|
| Pharmacogenomic Variants | 1 | 2017 | 35 | 0.140 |
Why?
|
| Administration, Oral | 2 | 2021 | 677 | 0.140 |
Why?
|
| Reflex, Startle | 4 | 2011 | 32 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 4 | 2002 | 1341 | 0.140 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 6470 | 0.140 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2017 | 22 | 0.140 |
Why?
|
| Sequence Deletion | 5 | 2006 | 528 | 0.140 |
Why?
|
| Viral Load | 3 | 2017 | 384 | 0.140 |
Why?
|
| Genetic Markers | 9 | 2002 | 606 | 0.140 |
Why?
|
| Hemiptera | 1 | 2016 | 10 | 0.140 |
Why?
|
| Membrane Transport Proteins | 2 | 2007 | 177 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 2 | 2011 | 250 | 0.140 |
Why?
|
| X Chromosome Inactivation | 2 | 2007 | 63 | 0.140 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 235 | 0.130 |
Why?
|
| Nitriles | 1 | 2017 | 146 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2016 | 14 | 0.130 |
Why?
|
| Virus Replication | 3 | 2011 | 609 | 0.130 |
Why?
|
| Hypocreales | 1 | 2016 | 2 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 378 | 0.130 |
Why?
|
| DNA Primers | 7 | 2001 | 660 | 0.130 |
Why?
|
| Ligand-Gated Ion Channels | 1 | 2016 | 1 | 0.130 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2016 | 2 | 0.130 |
Why?
|
| Gene Library | 10 | 2000 | 220 | 0.130 |
Why?
|
| Nematoda | 1 | 2016 | 16 | 0.130 |
Why?
|
| Simeprevir | 1 | 2016 | 1 | 0.130 |
Why?
|
| Bacteriophage T7 | 1 | 2015 | 3 | 0.130 |
Why?
|
| Arachnid Vectors | 1 | 2016 | 10 | 0.130 |
Why?
|
| Spinocerebellar Degenerations | 4 | 2005 | 64 | 0.130 |
Why?
|
| Protein Conformation | 1 | 2018 | 833 | 0.130 |
Why?
|
| Ixodes | 1 | 2016 | 15 | 0.130 |
Why?
|
| Founder Effect | 1 | 2015 | 31 | 0.130 |
Why?
|
| Deoxyribonuclease I | 1 | 1995 | 49 | 0.130 |
Why?
|
| Transfection | 6 | 2009 | 1069 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1996 | 150 | 0.120 |
Why?
|
| Acidosis | 1 | 2016 | 94 | 0.120 |
Why?
|
| Pregnancy | 8 | 2025 | 7167 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 260 | 0.120 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 597 | 0.120 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 1695 | 0.120 |
Why?
|
| Transcription Initiation Site | 2 | 2013 | 32 | 0.120 |
Why?
|
| Huntington Disease | 2 | 1993 | 143 | 0.120 |
Why?
|
| Computational Biology | 6 | 2018 | 820 | 0.120 |
Why?
|
| Fats | 1 | 2014 | 13 | 0.120 |
Why?
|
| Salvia miltiorrhiza | 1 | 2014 | 1 | 0.120 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2014 | 17 | 0.120 |
Why?
|
| Muscles | 1 | 1995 | 288 | 0.120 |
Why?
|
| Receptors, GABA-A | 1 | 2015 | 59 | 0.120 |
Why?
|
| Human Genome Project | 3 | 2001 | 55 | 0.120 |
Why?
|
| Species Specificity | 5 | 2018 | 548 | 0.120 |
Why?
|
| Models, Molecular | 1 | 2018 | 1074 | 0.120 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 169 | 0.120 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 49 | 0.120 |
Why?
|
| Glucagon | 1 | 2014 | 185 | 0.120 |
Why?
|
| Patient Safety | 1 | 2019 | 398 | 0.120 |
Why?
|
| Motor Activity | 4 | 2008 | 525 | 0.120 |
Why?
|
| Population Surveillance | 2 | 2013 | 389 | 0.120 |
Why?
|
| Genetic Complementation Test | 2 | 2011 | 87 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2022 | 840 | 0.110 |
Why?
|
| Macrocyclic Compounds | 1 | 2014 | 9 | 0.110 |
Why?
|
| Memory, Long-Term | 1 | 2014 | 42 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 337 | 0.110 |
Why?
|
| Houseflies | 1 | 2014 | 3 | 0.110 |
Why?
|
| Retroelements | 2 | 2011 | 41 | 0.110 |
Why?
|
| Lactams, Macrocyclic | 3 | 2021 | 18 | 0.110 |
Why?
|
| Genome, Bacterial | 3 | 2020 | 184 | 0.110 |
Why?
|
| Cells, Cultured | 10 | 2019 | 3050 | 0.110 |
Why?
|
| Point Mutation | 1 | 1995 | 348 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2018 | 1018 | 0.110 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 233 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2011 | 121 | 0.110 |
Why?
|
| Ritonavir | 1 | 2014 | 54 | 0.110 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2014 | 105 | 0.110 |
Why?
|
| Ribosomes | 1 | 2014 | 138 | 0.110 |
Why?
|
| Cyclopropanes | 3 | 2021 | 68 | 0.110 |
Why?
|
| DNA, Complementary | 5 | 1999 | 464 | 0.110 |
Why?
|
| Neuronal Plasticity | 3 | 2006 | 273 | 0.110 |
Why?
|
| Proline | 3 | 2021 | 77 | 0.110 |
Why?
|
| DNA-Directed DNA Polymerase | 2 | 1994 | 79 | 0.110 |
Why?
|
| Symbiosis | 1 | 2014 | 65 | 0.110 |
Why?
|
| RNA, Viral | 5 | 2021 | 539 | 0.110 |
Why?
|
| Nelumbo | 1 | 2013 | 1 | 0.110 |
Why?
|
| Astrocytes | 1 | 2016 | 249 | 0.110 |
Why?
|
| Bulbo-Spinal Atrophy, X-Linked | 1 | 2013 | 1 | 0.110 |
Why?
|
| Cryptochromes | 2 | 2014 | 7 | 0.110 |
Why?
|
| Nucleotides | 1 | 1993 | 92 | 0.110 |
Why?
|
| Models, Theoretical | 4 | 2021 | 358 | 0.110 |
Why?
|
| MicroRNAs | 3 | 2011 | 840 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2021 | 12287 | 0.110 |
Why?
|
| Sequence Homology | 2 | 2004 | 62 | 0.110 |
Why?
|
| Larva | 2 | 2016 | 248 | 0.110 |
Why?
|
| Blotting, Northern | 6 | 2001 | 259 | 0.110 |
Why?
|
| Amino Acid Motifs | 3 | 2019 | 200 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 455 | 0.110 |
Why?
|
| Plant Proteins | 4 | 2017 | 75 | 0.100 |
Why?
|
| Sequence Alignment | 5 | 2017 | 625 | 0.100 |
Why?
|
| Drug Combinations | 3 | 2021 | 266 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2019 | 519 | 0.100 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 257 | 0.100 |
Why?
|
| Insect Vectors | 1 | 2014 | 109 | 0.100 |
Why?
|
| RNA | 7 | 2013 | 568 | 0.100 |
Why?
|
| Muscle Strength | 1 | 2013 | 75 | 0.100 |
Why?
|
| Endometrial Ablation Techniques | 1 | 2012 | 3 | 0.100 |
Why?
|
| Frontotemporal Dementia | 1 | 2013 | 43 | 0.100 |
Why?
|
| Reishi | 1 | 2012 | 1 | 0.100 |
Why?
|
| United States | 7 | 2019 | 10773 | 0.100 |
Why?
|
| Dendrites | 3 | 2009 | 204 | 0.100 |
Why?
|
| Amygdala | 1 | 2013 | 80 | 0.100 |
Why?
|
| Lymphoproliferative Disorders | 4 | 1997 | 224 | 0.100 |
Why?
|
| Methylation | 7 | 1994 | 224 | 0.100 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2012 | 29 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2007 | 153 | 0.100 |
Why?
|
| Blotting, Western | 5 | 2007 | 1108 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 1995 | 418 | 0.100 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2012 | 58 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2007 | 1392 | 0.100 |
Why?
|
| Polymorphism, Genetic | 7 | 2015 | 810 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 1994 | 333 | 0.100 |
Why?
|
| Translocation, Genetic | 4 | 2018 | 356 | 0.100 |
Why?
|
| Adolescent | 8 | 2021 | 19358 | 0.100 |
Why?
|
| Sleep Wake Disorders | 1 | 2014 | 179 | 0.100 |
Why?
|
| Bryopsida | 2 | 2011 | 2 | 0.100 |
Why?
|
| Endosonography | 1 | 2012 | 79 | 0.100 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2017 | 449 | 0.100 |
Why?
|
| Cell Cycle Proteins | 3 | 2008 | 645 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2011 | 9 | 0.100 |
Why?
|
| Age Factors | 4 | 2016 | 2805 | 0.100 |
Why?
|
| In Situ Hybridization | 3 | 2009 | 470 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2011 | 17 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 1127 | 0.100 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 291 | 0.090 |
Why?
|
| Talin | 1 | 2011 | 8 | 0.090 |
Why?
|
| Desmoplakins | 1 | 2011 | 11 | 0.090 |
Why?
|
| Selaginellaceae | 1 | 2011 | 1 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 150 | 0.090 |
Why?
|
| Menorrhagia | 1 | 2012 | 74 | 0.090 |
Why?
|
| Acoustic Stimulation | 4 | 2020 | 85 | 0.090 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 3 | 1996 | 35 | 0.090 |
Why?
|
| Recurrence | 2 | 2012 | 1423 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2304 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 146 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 2 | 2009 | 280 | 0.090 |
Why?
|
| DNA Probes | 6 | 1993 | 124 | 0.090 |
Why?
|
| Liver | 3 | 2008 | 1761 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2025 | 1099 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2013 | 3268 | 0.090 |
Why?
|
| Sheep | 1 | 2011 | 212 | 0.090 |
Why?
|
| Models, Biological | 2 | 2016 | 1459 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2016 | 815 | 0.090 |
Why?
|
| Oligonucleotide Probes | 4 | 2002 | 85 | 0.090 |
Why?
|
| Nerve Degeneration | 1 | 2012 | 126 | 0.090 |
Why?
|
| Genetic Engineering | 2 | 2016 | 162 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 1756 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 998 | 0.090 |
Why?
|
| Chromosomes, Human | 2 | 1997 | 130 | 0.090 |
Why?
|
| Electrophysiology | 2 | 2008 | 270 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 391 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2011 | 207 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 507 | 0.090 |
Why?
|
| Chimera | 2 | 2018 | 88 | 0.090 |
Why?
|
| Nerve Net | 1 | 2013 | 239 | 0.090 |
Why?
|
| Mutagenesis, Insertional | 2 | 2008 | 147 | 0.090 |
Why?
|
| Self Report | 1 | 2013 | 522 | 0.090 |
Why?
|
| Argonaute Proteins | 2 | 2007 | 24 | 0.090 |
Why?
|
| Chromosome Aberrations | 3 | 2001 | 621 | 0.090 |
Why?
|
| Texas | 5 | 2025 | 3590 | 0.080 |
Why?
|
| Learning | 2 | 2011 | 363 | 0.080 |
Why?
|
| Nectria | 1 | 2009 | 1 | 0.080 |
Why?
|
| Intelligence | 2 | 1994 | 98 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2012 | 237 | 0.080 |
Why?
|
| Centromere | 3 | 2005 | 107 | 0.080 |
Why?
|
| Survival Rate | 2 | 2007 | 2020 | 0.080 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 475 | 0.080 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 169 | 0.080 |
Why?
|
| RNA Transport | 1 | 2009 | 9 | 0.080 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2009 | 13 | 0.080 |
Why?
|
| Anisomycin | 1 | 2009 | 2 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2012 | 486 | 0.080 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2009 | 35 | 0.080 |
Why?
|
| Genetic Testing | 4 | 2021 | 1004 | 0.080 |
Why?
|
| Registries | 1 | 2016 | 1411 | 0.080 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2009 | 26 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 717 | 0.080 |
Why?
|
| Biophysics | 1 | 2009 | 49 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 2 | 1986 | 51 | 0.080 |
Why?
|
| Aspergillus nidulans | 1 | 2008 | 23 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2417 | 0.080 |
Why?
|
| Homeostasis | 1 | 2013 | 692 | 0.080 |
Why?
|
| Introduced Species | 2 | 2020 | 22 | 0.080 |
Why?
|
| Cricetinae | 7 | 1994 | 411 | 0.080 |
Why?
|
| 2-Naphthylamine | 2 | 2021 | 6 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 1017 | 0.080 |
Why?
|
| Flavoproteins | 1 | 2008 | 17 | 0.080 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2008 | 12 | 0.080 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2020 | 43 | 0.080 |
Why?
|
| Salmo salar | 1 | 2008 | 3 | 0.080 |
Why?
|
| Cell Death | 1 | 2009 | 240 | 0.080 |
Why?
|
| Fish Diseases | 1 | 2008 | 10 | 0.080 |
Why?
|
| Vibrio Infections | 1 | 2008 | 16 | 0.080 |
Why?
|
| Operon | 1 | 2008 | 52 | 0.070 |
Why?
|
| Mice, Inbred Strains | 4 | 1999 | 311 | 0.070 |
Why?
|
| Electric Stimulation | 1 | 2009 | 323 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1604 | 0.070 |
Why?
|
| Genetic Carrier Screening | 5 | 1994 | 68 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2011 | 793 | 0.070 |
Why?
|
| Liver Transplantation | 2 | 2016 | 1039 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 1320 | 0.070 |
Why?
|
| Expressed Sequence Tags | 2 | 2006 | 78 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 95 | 0.070 |
Why?
|
| Pregnancy Outcome | 3 | 2017 | 589 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2013 | 813 | 0.070 |
Why?
|
| Genes, Bacterial | 1 | 2008 | 209 | 0.070 |
Why?
|
| Neoplasms | 1 | 2002 | 2801 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 266 | 0.070 |
Why?
|
| Chromosomes | 2 | 1987 | 199 | 0.070 |
Why?
|
| APACHE | 1 | 2007 | 52 | 0.070 |
Why?
|
| Cerebellum | 2 | 2013 | 416 | 0.070 |
Why?
|
| Epilepsy, Reflex | 1 | 2006 | 6 | 0.070 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 18 | 0.070 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2006 | 9 | 0.070 |
Why?
|
| Hybrid Cells | 6 | 1995 | 80 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 92 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 755 | 0.070 |
Why?
|
| Pyridines | 1 | 2008 | 229 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 963 | 0.070 |
Why?
|
| Iduronate Sulfatase | 2 | 1997 | 20 | 0.070 |
Why?
|
| Logistic Models | 2 | 2012 | 1804 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2008 | 229 | 0.070 |
Why?
|
| Protein Isoforms | 3 | 2009 | 412 | 0.070 |
Why?
|
| Limb Salvage | 1 | 2007 | 131 | 0.070 |
Why?
|
| Testis | 4 | 2005 | 410 | 0.070 |
Why?
|
| Information Services | 1 | 2006 | 22 | 0.070 |
Why?
|
| Conditioning, Classical | 2 | 2006 | 53 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 622 | 0.060 |
Why?
|
| Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1986 | 3 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 383 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 351 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2012 | 834 | 0.060 |
Why?
|
| Ataxin-10 | 1 | 2005 | 28 | 0.060 |
Why?
|
| Conditioning, Eyelid | 1 | 2005 | 7 | 0.060 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2005 | 13 | 0.060 |
Why?
|
| DNA Transposable Elements | 3 | 2011 | 177 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2018 | 16234 | 0.060 |
Why?
|
| Retroviridae | 1 | 1986 | 196 | 0.060 |
Why?
|
| Agar | 2 | 2016 | 16 | 0.060 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 141 | 0.060 |
Why?
|
| Georgia | 1 | 2025 | 30 | 0.060 |
Why?
|
| Transformation, Genetic | 2 | 1987 | 35 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2002 | 386 | 0.060 |
Why?
|
| Lower Extremity | 1 | 2007 | 187 | 0.060 |
Why?
|
| Flowers | 1 | 2024 | 7 | 0.060 |
Why?
|
| Chromosome Fragile Sites | 2 | 1995 | 4 | 0.060 |
Why?
|
| Protein Binding | 2 | 2020 | 1747 | 0.060 |
Why?
|
| Interferon Type I | 1 | 2005 | 107 | 0.060 |
Why?
|
| Social Behavior | 1 | 2006 | 209 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 369 | 0.060 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2017 | 46 | 0.060 |
Why?
|
| Karyotyping | 4 | 1998 | 330 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 163 | 0.060 |
Why?
|
| Culture Media | 2 | 2016 | 183 | 0.060 |
Why?
|
| Biological Transport | 2 | 2022 | 346 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2025 | 90 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2006 | 197 | 0.060 |
Why?
|
| Counseling | 1 | 2006 | 216 | 0.060 |
Why?
|
| Urochordata | 1 | 2004 | 1 | 0.060 |
Why?
|
| Tetraodontiformes | 1 | 2004 | 1 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2025 | 273 | 0.060 |
Why?
|
| Caenorhabditis | 1 | 2004 | 6 | 0.060 |
Why?
|
| Pharmacists | 1 | 2025 | 84 | 0.060 |
Why?
|
| Hindlimb | 1 | 2004 | 76 | 0.060 |
Why?
|
| Age of Onset | 1 | 2005 | 582 | 0.060 |
Why?
|
| Europe | 2 | 2005 | 352 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2017 | 643 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 292 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 1015 | 0.060 |
Why?
|
| Gene Rearrangement | 3 | 2000 | 320 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3068 | 0.050 |
Why?
|
| Infant, Newborn | 5 | 2017 | 8185 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2025 | 216 | 0.050 |
Why?
|
| RNA, Plant | 2 | 2014 | 8 | 0.050 |
Why?
|
| Cebidae | 1 | 2003 | 4 | 0.050 |
Why?
|
| Cercopithecidae | 1 | 2003 | 7 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2025 | 359 | 0.050 |
Why?
|
| Skull | 1 | 2004 | 142 | 0.050 |
Why?
|
| Neurofilament Proteins | 2 | 1995 | 28 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2019 | 753 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 1990 | 940 | 0.050 |
Why?
|
| Antigens, Neoplasm | 2 | 2005 | 382 | 0.050 |
Why?
|
| Anemia | 1 | 2007 | 341 | 0.050 |
Why?
|
| Binding Sites | 2 | 2018 | 1294 | 0.050 |
Why?
|
| Risk Factors | 7 | 2017 | 10149 | 0.050 |
Why?
|
| Marine Biology | 1 | 2022 | 2 | 0.050 |
Why?
|
| Longevity | 1 | 2004 | 140 | 0.050 |
Why?
|
| Diffusion | 1 | 2022 | 59 | 0.050 |
Why?
|
| Craniofacial Abnormalities | 1 | 2004 | 242 | 0.050 |
Why?
|
| Drug Resistance | 3 | 2017 | 256 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2003 | 162 | 0.050 |
Why?
|
| Mosaicism | 3 | 1995 | 241 | 0.050 |
Why?
|
| Oculocerebrorenal Syndrome | 2 | 1992 | 8 | 0.050 |
Why?
|
| Pan paniscus | 1 | 2002 | 2 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 225 | 0.050 |
Why?
|
| Hormones | 1 | 2023 | 187 | 0.050 |
Why?
|
| Plant Breeding | 1 | 2021 | 13 | 0.050 |
Why?
|
| Oligonucleotides | 2 | 2013 | 89 | 0.050 |
Why?
|
| Poaceae | 1 | 2021 | 12 | 0.050 |
Why?
|
| Triticum | 1 | 2021 | 34 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1417 | 0.050 |
Why?
|
| Fluorenes | 1 | 2021 | 7 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 93 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2025 | 443 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1994 | 135 | 0.050 |
Why?
|
| Electrophoresis, Capillary | 1 | 2021 | 12 | 0.050 |
Why?
|
| Cell Division | 2 | 2018 | 781 | 0.050 |
Why?
|
| Sustained Virologic Response | 1 | 2021 | 41 | 0.050 |
Why?
|
| Benzofurans | 1 | 2021 | 24 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2025 | 377 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2019 | 809 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 82 | 0.050 |
Why?
|
| Fructose Metabolism, Inborn Errors | 1 | 2021 | 1 | 0.050 |
Why?
|
| Myocardium | 2 | 2004 | 997 | 0.050 |
Why?
|
| Genotyping Techniques | 1 | 2021 | 103 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 121 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2024 | 473 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2002 | 179 | 0.050 |
Why?
|
| Proteome | 3 | 2011 | 241 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2001 | 165 | 0.050 |
Why?
|
| Chromosome Breakage | 2 | 1998 | 168 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2021 | 42 | 0.050 |
Why?
|
| Ataxia Telangiectasia | 1 | 2000 | 15 | 0.050 |
Why?
|
| Epilepsy | 2 | 2006 | 872 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 51 | 0.040 |
Why?
|
| Chromosome Banding | 2 | 1998 | 139 | 0.040 |
Why?
|
| Gene Products, rev | 1 | 2000 | 11 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2025 | 546 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2025 | 1186 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 192 | 0.040 |
Why?
|
| Plasmids | 2 | 2013 | 514 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2009 | 1684 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2000 | 103 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2000 | 94 | 0.040 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2000 | 3 | 0.040 |
Why?
|
| Genome Size | 1 | 2020 | 15 | 0.040 |
Why?
|
| Mental Disorders | 2 | 2000 | 824 | 0.040 |
Why?
|
| Cell Nucleolus | 1 | 2000 | 56 | 0.040 |
Why?
|
| Mucopolysaccharidosis II | 2 | 1997 | 18 | 0.040 |
Why?
|
| Karyopherins | 1 | 2000 | 36 | 0.040 |
Why?
|
| Gamma Rhythm | 1 | 2020 | 12 | 0.040 |
Why?
|
| Magnoliopsida | 2 | 2011 | 4 | 0.040 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 2 | 2011 | 13 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2018 | 1482 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2002 | 238 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2006 | 772 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2020 | 136 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2022 | 261 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 535 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2019 | 25 | 0.040 |
Why?
|
| Sex Chromosome Aberrations | 3 | 1993 | 56 | 0.040 |
Why?
|
| Guanine Nucleotides | 1 | 1998 | 15 | 0.040 |
Why?
|
| Software | 1 | 2024 | 685 | 0.040 |
Why?
|
| Chromosomes, Plant | 1 | 2018 | 7 | 0.040 |
Why?
|
| Sorghum | 1 | 2018 | 3 | 0.040 |
Why?
|
| Adenine Nucleotides | 1 | 1998 | 41 | 0.040 |
Why?
|
| Reproduction | 1 | 2021 | 239 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 1998 | 30 | 0.040 |
Why?
|
| Hydrodynamics | 1 | 2018 | 25 | 0.040 |
Why?
|
| Dendritic Spines | 2 | 2011 | 60 | 0.040 |
Why?
|
| Pongo pygmaeus | 1 | 1998 | 7 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 848 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 6089 | 0.040 |
Why?
|
| DNA Replication | 2 | 2000 | 350 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5107 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 79 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 48 | 0.040 |
Why?
|
| Forecasting | 2 | 2001 | 351 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 57 | 0.040 |
Why?
|
| Base Composition | 2 | 2009 | 72 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 31 | 0.040 |
Why?
|
| Aminoisobutyric Acids | 1 | 2017 | 9 | 0.040 |
Why?
|
| Lymphocytes | 2 | 1996 | 406 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1998 | 106 | 0.040 |
Why?
|
| Heme | 1 | 2018 | 53 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 304 | 0.040 |
Why?
|
| Data Mining | 1 | 2018 | 54 | 0.040 |
Why?
|
| Situs Inversus | 1 | 1997 | 25 | 0.040 |
Why?
|
| Chromosome Duplication | 1 | 2018 | 147 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 243 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 467 | 0.040 |
Why?
|
| Ribonuclease III | 2 | 2011 | 89 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2002 | 1404 | 0.040 |
Why?
|
| Child | 5 | 2014 | 24528 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 775 | 0.040 |
Why?
|
| Adrenoleukodystrophy | 1 | 1997 | 9 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 297 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 348 | 0.040 |
Why?
|
| Disease Progression | 2 | 2018 | 2042 | 0.040 |
Why?
|
| Plant Viruses | 1 | 2016 | 2 | 0.030 |
Why?
|
| Trees | 1 | 2016 | 9 | 0.030 |
Why?
|
| Chromosome Walking | 2 | 1995 | 8 | 0.030 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1996 | 15 | 0.030 |
Why?
|
| Proteomics | 1 | 2020 | 491 | 0.030 |
Why?
|
| Jews | 1 | 1997 | 32 | 0.030 |
Why?
|
| 5-Methylcytosine | 2 | 2013 | 32 | 0.030 |
Why?
|
| Hylobates | 1 | 1996 | 10 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 184 | 0.030 |
Why?
|
| Cycloheximide | 1 | 2016 | 43 | 0.030 |
Why?
|
| Dinucleoside Phosphates | 1 | 1996 | 11 | 0.030 |
Why?
|
| COS Cells | 2 | 2011 | 276 | 0.030 |
Why?
|
| Ataxins | 3 | 2005 | 114 | 0.030 |
Why?
|
| Leucine | 1 | 2017 | 310 | 0.030 |
Why?
|
| Creatine | 1 | 1996 | 41 | 0.030 |
Why?
|
| Gene Pool | 1 | 2015 | 5 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2000 | 889 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 305 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 2016 | 103 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2017 | 3382 | 0.030 |
Why?
|
| Travel | 1 | 2017 | 116 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2016 | 125 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2014 | 820 | 0.030 |
Why?
|
| Amino Acids | 2 | 2014 | 663 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 267 | 0.030 |
Why?
|
| Lyme Disease | 1 | 2016 | 35 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2015 | 60 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2000 | 459 | 0.030 |
Why?
|
| Child Behavior Disorders | 1 | 1996 | 67 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1995 | 51 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 4 | 1997 | 45 | 0.030 |
Why?
|
| Quality of Life | 1 | 2025 | 1954 | 0.030 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2015 | 7 | 0.030 |
Why?
|
| Pregnanolone | 1 | 2015 | 11 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 79 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1986 | 120 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 169 | 0.030 |
Why?
|
| Thyroxine | 1 | 2015 | 69 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 868 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2011 | 395 | 0.030 |
Why?
|
| Laboratories | 1 | 2015 | 82 | 0.030 |
Why?
|
| Ethidium | 1 | 1994 | 8 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2122 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2017 | 171 | 0.030 |
Why?
|
| Macromolecular Substances | 3 | 1995 | 185 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2016 | 363 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 59 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1930 | 0.030 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2003 | 793 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2015 | 74 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2014 | 87 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2873 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 2006 | 124 | 0.030 |
Why?
|
| Fathers | 1 | 1994 | 68 | 0.030 |
Why?
|
| Terminator Regions, Genetic | 1 | 2013 | 7 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2013 | 59 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 253 | 0.030 |
Why?
|
| Infant | 4 | 2014 | 12481 | 0.030 |
Why?
|
| Skin | 1 | 1996 | 511 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Spinal Cord | 1 | 1995 | 302 | 0.030 |
Why?
|
| Vitis | 1 | 2013 | 14 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 26 | 0.030 |
Why?
|
| Action Potentials | 1 | 2016 | 500 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 33 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 870 | 0.030 |
Why?
|
| Vertebrates | 1 | 2013 | 41 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2013 | 66 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2013 | 132 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 2013 | 70 | 0.030 |
Why?
|
| Contig Mapping | 2 | 2005 | 55 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 154 | 0.030 |
Why?
|
| Extremities | 1 | 2013 | 83 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 1008 | 0.030 |
Why?
|
| Syndrome | 1 | 1995 | 1125 | 0.030 |
Why?
|
| Gene Dosage | 3 | 1994 | 441 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2013 | 210 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 328 | 0.030 |
Why?
|
| CpG Islands | 2 | 2006 | 323 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 316 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2013 | 211 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 2 | 2005 | 221 | 0.020 |
Why?
|
| Phospholipase A2 Inhibitors | 1 | 2012 | 3 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2013 | 140 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 835 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2017 | 987 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2013 | 137 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1992 | 101 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 426 | 0.020 |
Why?
|
| DEAD Box Protein 58 | 1 | 2011 | 12 | 0.020 |
Why?
|
| Placenta | 1 | 1996 | 506 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1333 | 0.020 |
Why?
|
| Interferons | 1 | 2012 | 123 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 393 | 0.020 |
Why?
|
| Ion Channels | 1 | 2013 | 193 | 0.020 |
Why?
|
| Penetrance | 1 | 2012 | 103 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1991 | 17 | 0.020 |
Why?
|
| Costameres | 1 | 2011 | 1 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 152 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 2011 | 7 | 0.020 |
Why?
|
| Desmosomes | 1 | 2011 | 7 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1991 | 49 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 237 | 0.020 |
Why?
|
| Chlamydomonas | 1 | 2011 | 5 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2011 | 52 | 0.020 |
Why?
|
| Myofibrils | 1 | 2011 | 28 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2011 | 30 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 295 | 0.020 |
Why?
|
| RNA Editing | 1 | 2011 | 33 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2005 | 938 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 128 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2013 | 222 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 109 | 0.020 |
Why?
|
| DNA Repair | 2 | 2007 | 588 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 79 | 0.020 |
Why?
|
| RNA, Heterogeneous Nuclear | 1 | 1990 | 4 | 0.020 |
Why?
|
| Vagina | 1 | 2012 | 195 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 53 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1995 | 1625 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 43 | 0.020 |
Why?
|
| Pigments, Biological | 1 | 2010 | 7 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 337 | 0.020 |
Why?
|
| Poly A | 1 | 1990 | 59 | 0.020 |
Why?
|
| Eukaryota | 1 | 2010 | 21 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 1894 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 1619 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 492 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 124 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 749 | 0.020 |
Why?
|
| Genes, Dominant | 2 | 2004 | 247 | 0.020 |
Why?
|
| Metaphase | 2 | 1993 | 44 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2088 | 0.020 |
Why?
|
| Liver Neoplasms | 3 | 2005 | 1319 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2000 | 70 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1990 | 395 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 510 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1246 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2011 | 190 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 1064 | 0.020 |
Why?
|
| Psychophysics | 1 | 2008 | 14 | 0.020 |
Why?
|
| Fungi | 1 | 2009 | 69 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 387 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1996 | 810 | 0.020 |
Why?
|
| Leukocytes | 2 | 2004 | 206 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 578 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1237 | 0.020 |
Why?
|
| Spermatozoa | 2 | 2004 | 224 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 184 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4554 | 0.020 |
Why?
|
| Appetitive Behavior | 1 | 2008 | 14 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1514 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 1321 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 53 | 0.020 |
Why?
|
| Reaction Time | 1 | 2008 | 170 | 0.020 |
Why?
|
| DNA, Algal | 1 | 2007 | 1 | 0.020 |
Why?
|
| Locomotion | 1 | 2008 | 69 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 314 | 0.020 |
Why?
|
| Chloroplasts | 1 | 2007 | 10 | 0.020 |
Why?
|
| Flagella | 1 | 2007 | 28 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1207 | 0.020 |
Why?
|
| Kidney | 1 | 1995 | 1345 | 0.020 |
Why?
|
| Photosynthesis | 1 | 2007 | 10 | 0.020 |
Why?
|
| Oryza | 1 | 2007 | 24 | 0.020 |
Why?
|
| Dehydration | 1 | 2007 | 39 | 0.020 |
Why?
|
| DNA, Single-Stranded | 3 | 1993 | 75 | 0.020 |
Why?
|
| Ouabain | 1 | 1987 | 27 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 3341 | 0.020 |
Why?
|
| Neomycin | 2 | 1984 | 37 | 0.020 |
Why?
|
| CELF1 Protein | 1 | 2007 | 48 | 0.020 |
Why?
|
| Arabidopsis | 1 | 2007 | 70 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 199 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1987 | 100 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2014 | 14085 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 1990 | 1015 | 0.020 |
Why?
|
| Somatosensory Disorders | 1 | 2006 | 4 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 19 | 0.020 |
Why?
|
| Ataxin-1 | 2 | 1998 | 162 | 0.020 |
Why?
|
| Motor Skills | 1 | 2006 | 83 | 0.020 |
Why?
|
| Synteny | 1 | 2006 | 74 | 0.020 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 1 | 2005 | 1 | 0.020 |
Why?
|
| Adenosine Deaminase | 1 | 1986 | 74 | 0.020 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2005 | 15 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2005 | 11 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 2005 | 13 | 0.020 |
Why?
|
| Utah | 1 | 2005 | 46 | 0.020 |
Why?
|
| Replicon | 1 | 2005 | 6 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2005 | 23 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2007 | 196 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2005 | 23 | 0.020 |
Why?
|
| Telephone | 1 | 2006 | 110 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 223 | 0.020 |
Why?
|
| Drug Resistance, Viral | 1 | 2005 | 44 | 0.020 |
Why?
|
| Janus Kinases | 1 | 2005 | 31 | 0.020 |
Why?
|
| Neutropenia | 1 | 2007 | 201 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 337 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2005 | 72 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 182 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 50 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 853 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 46 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 226 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2007 | 355 | 0.010 |
Why?
|
| Aging | 2 | 2006 | 1184 | 0.010 |
Why?
|
| Dogs | 1 | 1986 | 767 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 384 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 3427 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 211 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2005 | 173 | 0.010 |
Why?
|
| Drug Stability | 1 | 2004 | 57 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1986 | 261 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 51 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 151 | 0.010 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2005 | 191 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2005 | 215 | 0.010 |
Why?
|
| Genes, myc | 1 | 2004 | 99 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2004 | 112 | 0.010 |
Why?
|
| False Negative Reactions | 2 | 1994 | 89 | 0.010 |
Why?
|
| False Positive Reactions | 2 | 1994 | 144 | 0.010 |
Why?
|
| Neuromuscular Junction | 1 | 2004 | 92 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 86 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 413 | 0.010 |
Why?
|
| Memory | 1 | 2006 | 363 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1986 | 578 | 0.010 |
Why?
|
| Germ Cells | 1 | 2004 | 195 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 75 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 1129 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2004 | 571 | 0.010 |
Why?
|
| beta Catenin | 1 | 2004 | 206 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1994 | 775 | 0.010 |
Why?
|
| Hyperkinesis | 1 | 2002 | 24 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2002 | 136 | 0.010 |
Why?
|
| Gene Order | 1 | 2001 | 79 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1984 | 469 | 0.010 |
Why?
|
| Meiosis | 1 | 1991 | 115 | 0.010 |
Why?
|
| Maze Learning | 1 | 2002 | 128 | 0.010 |
Why?
|
| Smoking | 1 | 2007 | 1037 | 0.010 |
Why?
|
| GC Rich Sequence | 1 | 2001 | 6 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2001 | 121 | 0.010 |
Why?
|
| Public Sector | 1 | 2001 | 13 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 348 | 0.010 |
Why?
|
| Private Sector | 1 | 2001 | 24 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 672 | 0.010 |
Why?
|
| Drug Industry | 1 | 2001 | 46 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1888 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 2000 | 17 | 0.010 |
Why?
|
| Filamins | 1 | 2000 | 25 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 619 | 0.010 |
Why?
|
| Heteroduplex Analysis | 1 | 2000 | 4 | 0.010 |
Why?
|
| Euchromatin | 1 | 2000 | 13 | 0.010 |
Why?
|
| Neuroglia | 1 | 2002 | 201 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2000 | 49 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2000 | 65 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2000 | 116 | 0.010 |
Why?
|
| Dyskeratosis Congenita | 1 | 1999 | 19 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2000 | 123 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 168 | 0.010 |
Why?
|
| Anxiety | 1 | 2006 | 966 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2000 | 127 | 0.010 |
Why?
|
| Incidence | 1 | 2007 | 3086 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 291 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 224 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2000 | 204 | 0.010 |
Why?
|
| Fetus | 2 | 1993 | 584 | 0.010 |
Why?
|
| TATA Box | 1 | 1998 | 25 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2000 | 274 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 1998 | 150 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 54 | 0.010 |
Why?
|
| Cricetulus | 2 | 1990 | 97 | 0.010 |
Why?
|
| Body Patterning | 1 | 1997 | 124 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1997 | 121 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 383 | 0.010 |
Why?
|
| Tunisia | 1 | 1997 | 4 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1998 | 286 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1789 | 0.010 |
Why?
|
| Israel | 1 | 1997 | 45 | 0.010 |
Why?
|
| Arabs | 1 | 1997 | 29 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 1996 | 24 | 0.010 |
Why?
|
| Chromatin | 1 | 2000 | 554 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1995 | 67 | 0.010 |
Why?
|
| Abortion, Habitual | 1 | 1995 | 16 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 76 | 0.010 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 1995 | 8 | 0.010 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 1995 | 3 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 1995 | 12 | 0.010 |
Why?
|
| Host Cell Factor C1 | 1 | 1995 | 9 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1994 | 18 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 323 | 0.010 |
Why?
|
| Ontario | 1 | 1994 | 65 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 1997 | 546 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1997 | 802 | 0.010 |
Why?
|
| Minnesota | 1 | 1994 | 132 | 0.010 |
Why?
|
| Interphase | 1 | 1993 | 45 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1995 | 318 | 0.010 |
Why?
|
| Reference Values | 1 | 1994 | 709 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 1994 | 282 | 0.010 |
Why?
|
| Germany | 1 | 1993 | 66 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 143 | 0.010 |
Why?
|
| Macropodidae | 1 | 1992 | 8 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1993 | 92 | 0.010 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 1992 | 6 | 0.010 |
Why?
|
| Chorionic Villi Sampling | 1 | 1992 | 45 | 0.010 |
Why?
|
| Axons | 1 | 1995 | 393 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1993 | 142 | 0.010 |
Why?
|
| Seizures | 1 | 1997 | 878 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1992 | 208 | 0.010 |
Why?
|
| Cattle | 1 | 1992 | 563 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1993 | 1006 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1990 | 6 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1992 | 276 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1990 | 392 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 2433 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1993 | 671 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 2030 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1997 | 1817 | 0.000 |
Why?
|
| Sterols | 1 | 1984 | 16 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1984 | 100 | 0.000 |
Why?
|
| Receptors, LDL | 1 | 1984 | 89 | 0.000 |
Why?
|